← Leaderboards
Robert James Mason
National Jewish Health
$10,199,421
Attributed
$10,199,421
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.6M · FY2005–13$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$22,213,290 · 16
By mechanism
P50$11,065,162 · 4
P01$3,385,338 · 3
R01$2,885,094 · 1
U01$2,391,141 · 1
P20$1,720,762 · 4
R21$435,875 · 1
Top collaborators
No co-investigators on record.
Most similar at National Jewish Health
Same institution · by research overlap
- Dennis R Voelker$17,845,148
- Carl W White$29,966,481
- Kevin K Brown$1,028,883
- Robert Carl Murphy$18,062,548
- Willi K Born$4,873,117
Others in their field
Top investigators on “Pulmonary Surfactants”
- Michael Francis Beers · University Of Pennsylvania$15,789,471
- Ravi Kalhan · Northwestern University At Chicago$15,411,918
- Bruce C Trapnell · Children'S Hospital Med Ctr (Cincinnati)$14,946,085
- Roberta Anderson Ballard · Children'S Hospital Of Philadelphia$14,319,457
- Jo Rae Wright · Duke University$13,499,544
- Francis Sessions Cole · Washington University$12,805,803
Research focus
Pulmonary SurfactantsAlveolar Type Ii CellPulmonary Fibrosis /GranulomaTissue /Cell CulturePhospholipidsLipid BiosynthesisProductionRespiratory EpitheliumGenesPneumoniaRegulationAlveolarPathway InteractionsLaboratory RatType Ii Epithelial Receptor CellCellsFibroblast Growth FactorTranscription FactorLaboratory MouseTherapeutic TargetCell TypeFutureEpithelial CellsFibroblasts
Grant awards (39)
Alveolar type II cell innate immune response to influenza$407,809
U01 · FY2013 · AI · contact PI
Alveolar type II cell innate immune response to influenza$433,839
U01 · FY2012 · AI · contact PI
Air/liquid interface cultures for alveolar type II cell differentiation$198,125
R21 · FY2012 · HL · contact PI
Alveolar type II cell innate immune response to influenza$434,012
U01 · FY2011 · AI · contact PI
Air/liquid interface cultures for alveolar type II cell differentiation$237,750
R21 · FY2011 · HL · contact PI
Alveolar type II cell innate immune response to influenza$438,383
U01 · FY2010 · AI · contact PI
Alveolar type II cell innate immune response to influenza$247,185
U01 · FY2010 · AI · contact PI
Alveolar type II cell innate immune response to influenza$429,913
U01 · FY2009 · AI · contact PI
Alveolar Type II Cells in Vitro: Effect of KGF$357,791
R01 · FY2009 · HL · contact PI
Alveolar Type II Cells in Vitro: Effect of KGF$378,510
R01 · FY2008 · HL · contact PI
Type II Pneumocyte Interactions with SARS-CoV$339,082
P01 · FY2008 · AI · contact PI
DE PEDIATRIC COBRE: CELL SCIENCE CORE$265,310
P20 · FY2008 · RR · contact PI
Alveolar Type II Cells in Vitro: Effect of KGF$379,714
R01 · FY2007 · HL · contact PI
Type II Pneumocyte Interactions with SARS-CoV$334,145
P01 · FY2007 · AI · contact PI
DE PEDIATRIC COBRE: CELL SCIENCE CORE$268,220
P20 · FY2007 · RR · contact PI
Alveolar Type II Cells in Vitro: Effect of KGF$400,179
R01 · FY2006 · HL · contact PI
Type II Pneumocyte Interactions with SARS-CoV$342,672
P01 · FY2006 · AI · contact PI
DE PEDIATRIC COBRE: CELL SCIENCE CORE$266,061
P20 · FY2006 · RR · contact PI
SCOR: Pathobiology of Fibrotic Lung Disease$1,885,820
P50 · FY2005 · HL
DE PEDIATRIC COBRE: CELL SCIENCE CORE$409,309
P20 · FY2005 · RR
Type II Pneumocyte Interactions with SARS-CoV$325,449
P01 · FY2005 · AI
SCOR: Pathobiology of Fibrotic Lung Disease$1,830,893
P50 · FY2004 · HL
CORE--DE PEDIATRIC COBRE: CELL SCIENCE CORE$511,862
P20 · FY2004 · RR
Type II Pneumocyte Interactions with SARS-CoV$348,780
P01 · FY2004 · AI
Alveolar Type II Cells in vitro: Effect of KGF$342,225
R01 · FY2004 · HL
SCOR: Pathobiology of Fibrotic Lung Disease$1,777,566
P50 · FY2003 · HL
Alveolar Type II Cells in vitro: Effect of KGF$342,225
R01 · FY2003 · HL
SCOR: Pathobiology of Fibrotic Lung Disease$1,732,194
P50 · FY2002 · HL
Alveolar Type II Cells in vitro: Effect of KGF$342,225
R01 · FY2002 · HL
Alveolar epithelium in pulmonary fibrosis$288,699
P50 · FY2002 · HL
Conference:Lung Surfactant:Cellular &Molecular Biology$25,000
R13 · FY2002 · HL
SCOR: Pathobiology of Fibrotic Lung Disease$1,695,210
P01 · FY2001 · HL
IMMUNOLOGIC REGULATION OF PULMONARY FIBROSIS$1,558,969
P50 · FY2001 · HL
Alveolar Type II Cells in vitro: Effect of KGF$342,225
R01 · FY2001 · HL
EPITHELIAL REGULATION OF PULMONARY FIBROSIS$208,827
P50 · FY2001 · HL
Alveolar epithelium in pulmonary fibrosis$0
P01 · FY2001 · HL
IMMUNOLOGIC REGULATION OF PULMONARY FIBROSIS$1,533,217
P50 · FY2000 · HL
FUNCTIONS OF PULMONARY ALVEOLAR TYPE II CELLS IN VITRO$304,918
R37 · FY2000 · HL
EPITHELIAL REGULATION OF PULMONARY FIBROSIS$248,977
P50 · FY2000 · HL